| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Diamedica Therapeutics Inc. (DMAC) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. DMAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.83M | $51.63M | - | |
| 10% | 8.38M | $49.04M | - | |
| 10% | 4.96M | $29.01M | - | |
| Other | 450.0K | $2.63M | - | |
| Dir | 398.6K | $2.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Kellen Scott | CFO And Secretary | Buy | 10,000 | $3.15 | $31,463.00 | +81.4% | +22.5% | -44.1% | |
| Dec 4, 2020 | Pilnik Richard D.47 | Director | Buy | 10,000 | $5.37 | $53,697.00 | +7.9% | - | - | |
| Nov 20, 2020 | Giuffre Randall Michael84 | Director | Buy | 15,000 | $4.26 | $63,912.00 | +16.0% | - | - | |
| Nov 9, 2020 | Kellen Scott | CFO And Secretary | Buy | 2,000 | $4.19 | $8,386.60 | +19.4% | - | - | |
| Aug 19, 2019 | Kellen Scott | CFO And Secretary | Buy | 3,000 | $2.43 | $7,290.00 | +41.2% | - | - | |
| Aug 16, 2019 | Alcorn Harry W Jr | Chief Medical Officer | Buy | 7,260 | $2.67 | $19,365.32 | +726.0% | - | - | |
| Aug 16, 2019 | Pauls Dietrich John49 | President And CEO | Buy | 1,000 | $2.68 | $2,676.90 | +3.4% | - | - | |
| Aug 16, 2019 | Pilnik Richard D.47 | Director | Buy | 7,840 | $2.56 | $20,039.04 | +18.3% | - | - | |
| May 31, 2019 | Pilnik Richard D.47 | Director | Buy | 19,000 | $2.80 | $53,200.00 | +79.7% | - | - | |
| May 24, 2019 | Kellen Scott | CFO And Secretary | Buy | 4,000 | $2.94 | $11,770.00 | +121.6% | - | - |